Skip to main content

Advertisement

Volume 10 Supplement 1

de Senectute: Age and Health Forum

Pharmacological therapy of osteoporosis

Article metrics

  • 1229 Accesses

Osteoporosis is a disease associated with an increased risk of fractures. Vertebral and hip fractures are associated with high mortality or loss of autonomy. The aim of this review is to explore the scientific evidence for current therapies for postmenopausal osteoporosis and fractures and to establish how to treat osteoporosis in clinical practice without risk for patients.

We performed research by the use of pubmed of all randomized controlled trials on osteoporosis therapy. The key works used were “osteoporosis therapy”; “postmenopausal osteoporosis” and “osteoporosis trial”.

Efficacious pharmacological therapy include alendronate, risedronate, hormone replacement therapy, strontium ranelate, that are successful agents for femoral and vertebral sites. All osteoporosis patients may take calcium and vitamin D supplementation often not recommended by the physicians. Treatment of Osteopenic patients need further evidence. Early diagnosis and treatment can help to reduce the complications such as fractures but adverse effects may be monitoring and need particular knowledge in this setting [14].

References

  1. 1.

    NIH Consensus Development Panel on Osteoporosis Prevention: Diagnosis and Therapy. Osteoporosis prevention diagnosis, and therapy. JAMA. 2001, 285: 785-95.

  2. 2.

    Fleisch H: Bisphosphonates in osteoporosis. Br J Clin Pract. 1994, 48: 323-6.

  3. 3.

    Writing Group for the Women’s Health Initiative investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women—principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-33. 10.1001/jama.288.3.321.

  4. 4.

    McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, et al: Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med. 2001, 344: 333-40. 10.1056/NEJM200102013440503.

Download references

Author information

Correspondence to T Montalcini.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Montalcini, T., Gorgone, G., Fava, A. et al. Pharmacological therapy of osteoporosis. BMC Geriatr 10, L24 (2010) doi:10.1186/1471-2318-10-S1-L24

Download citation

Keywords

  • Osteoporosis
  • Strontium
  • Hormone Replacement Therapy
  • Alendronate
  • Scientific Evidence